| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Aldrich Richard serves as a Director at KALV and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $8.0M at current prices.
The biggest single holding is KALV (~$8.0M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 565,065 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2017 | KALV Kalvista Pharmaceuticals, Inc. | Director | Buy | 565,065 | $8.61 | $4,866,961.35 | +153.0% | |
| Jun 1, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 425,000 | $7.00 | $2,975,000.00 | +79.1% | |
| May 18, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 20,000 | $7.86 | $157,200.00 | +3.9% | |
| May 17, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 40,000 | $7.63 | $305,000.00 | +8.4% | |
| May 13, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 36,095 | $6.94 | $250,394.70 | +8.2% | |
| May 11, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 20,000 | $7.64 | $152,800.00 | +4.8% | |
| May 10, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 19,900 | $7.72 | $153,628.00 | +5.0% | |
| Mar 24, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 59,800 | $9.49 | $567,240.39 | +17.5% | |
| Mar 22, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 59,800 | $10.44 | $624,513.61 | +21.2% | |
| Mar 18, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 59,700 | $8.26 | $492,962.43 | +26.9% |